Clinical Trials Browser

Phase 1/2 × Unknown × Carcinoma, Neuroendocrine × Clear all

NCT05747729 2023-02-28

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Phase 1/2 Unknown

Carcinoma, Neuroendocrine

NCT02038738 2014-01-17

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Phase 1/2 Unknown

Apudoma, Carcinoid Tumor, Adenoma, Islet Cell, Carcinoma, Neuroendocrine, Neuroendocrine Tumors